Teva Pharmaceutical Industries Ltd.
A biopharmaceutical firm that develops and markets generic and specialty medicines.
TEVA | TA
Overview
Corporate Details
- ISIN(s):
- US8816242098 (+1 more)
- LEI:
- 549300BAFGM4RC74ZJ94
- Country:
- Israel
- Address:
- 124 DVORA HANEVIA, 6944020 TEL AVIV
- Website:
- https://www.tevapharm.com/
- Sector:
- Manufacturing
Description
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical company that develops, produces, and markets a broad portfolio of medicines. The company's business is centered on two main segments: generic medicines and innovative specialty treatments. As one of the world's largest manufacturers of generic drugs, Teva provides a wide range of affordable products across numerous therapeutic areas. Its specialty and biopharmaceutical research focuses on developing novel treatments, with a significant emphasis on central nervous system (CNS) disorders, including therapies for schizophrenia, tardive dyskinesia, and bipolar disorder. The company's portfolio also includes complex generics, biosimilars, and active pharmaceutical ingredients (APIs), while leveraging advanced technologies to enhance drug development and manufacturing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-18 18:38 | English | 7.1 KB | |||
| 2025-02-15 00:13 |
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Sabag Mark
|
English | 17.2 KB | ||
| 2025-02-15 00:13 |
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Sabag Mark
|
English | 36.2 KB | ||
| 2025-02-14 22:03 |
4
|
English | 7.2 KB | ||
| 2025-02-13 14:06 | English | 7.0 KB | |||
| 2025-02-12 15:22 | English | 11.3 KB | |||
| 2025-02-08 00:32 |
FORM S-3 - PROSPECTUS
|
English | 530.0 KB | ||
| 2025-02-08 00:32 |
FORM S-3 - PROSPECTUS
|
English | 36.2 KB | ||
| 2025-02-07 22:21 |
S-3ASR
|
English | 463.9 KB | ||
| 2025-02-06 00:19 |
FORM 10k For the fiscal year ended December 31, 2024
|
English | 866.8 KB | ||
| 2025-02-06 00:19 |
FORM 10k For the fiscal year ended December 31, 2024
|
English | 36.3 KB | ||
| 2025-02-05 22:09 |
10-K
|
English | 4.6 MB | ||
| 2025-01-31 00:16 |
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Daniell Richa…
|
English | 17.3 KB | ||
| 2025-01-31 00:16 |
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Daniell Richa…
|
English | 36.2 KB | ||
| 2025-01-31 00:16 |
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Sabag Mark
|
English | 17.3 KB |
Automate Your Workflow. Get a real-time feed of all Teva Pharmaceutical Industries Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Teva Pharmaceutical Industries Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Teva Pharmaceutical Industries Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
